1. Home
  2. TG vs IMRX Comparison

TG vs IMRX Comparison

Compare TG & IMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tredegar Corporation

TG

Tredegar Corporation

HOLD

Current Price

$7.21

Market Cap

239.6M

Sector

Industrials

ML Signal

HOLD

Logo Immuneering Corporation

IMRX

Immuneering Corporation

HOLD

Current Price

$3.73

Market Cap

232.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TG
IMRX
Founded
1988
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
239.6M
232.3M
IPO Year
1994
2021

Fundamental Metrics

Financial Performance
Metric
TG
IMRX
Price
$7.21
$3.73
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
★ $17.17
AVG Volume (30 Days)
181.3K
★ 663.0K
Earning Date
11-06-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 151.06
37.75
EPS
★ 0.34
N/A
Revenue
★ $800,821,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$23.62
★ N/A
Revenue Growth
★ 8.29
N/A
52 Week Low
$6.25
$3.38
52 Week High
$10.53
$8.48

Technical Indicators

Market Signals
Indicator
TG
IMRX
Relative Strength Index (RSI) 42.88 40.61
Support Level $7.16 $3.38
Resistance Level $8.21 $5.32
Average True Range (ATR) 0.30 0.20
MACD 0.04 0.03
Stochastic Oscillator 17.32 48.59

Price Performance

Historical Comparison
TG
IMRX

About TG Tredegar Corporation

Tredegar Corp is engaged in the manufacture of aluminum extrusions and polyethylene and polypropylene plastic films. It produces surface protection films, packaging films and films for other markets. The company continues to have two reportable segments: Aluminum Extrusions and High Performance Films. The majority of the revenue is derived form the Aluminum Extrusions segment which produces high-quality, soft and medium strength alloyed aluminum extrusions, custom fabricated and finished, for the building and construction, automotive and transportation, consumer durables goods, machinery and equipment, electrical and renewable energy, and distribution markets.

About IMRX Immuneering Corporation

Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.

Share on Social Networks: